HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kenneth W Locke Selected Research

4- (6- acetyl- 3- (3- (4- acetyl- 3- hydroxy- 2- propylphenylthio)propoxy)- 2- propylphenoxy)butyric acid

8/2006MN-001, a novel oral anti-inflammatory agent, suppresses bladder hyperactivity in a rat model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kenneth W Locke Research Topics

Disease

1Interstitial Cystitis (Interstitial Cystitis, Chronic)
08/2006
1Ischemic Stroke
02/2004
1Brain Ischemia (Cerebral Ischemia)
02/2004
1Ischemia
02/2004
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
02/2004

Drug/Important Bio-Agent (IBA)

14- (6- acetyl- 3- (3- (4- acetyl- 3- hydroxy- 2- propylphenylthio)propoxy)- 2- propylphenoxy)butyric acidIBA
08/2006
1Cytidine Diphosphate Choline (Citicoline)IBA
02/2004
1Lamotrigine (Lamictal)FDA LinkGeneric
02/2004